Edward L Y Chen

5PUBLICATIONS
36CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
Goblet cells tune ILC2 activity through a gut-specific response checkpoint.

|Mar 14, 2025
CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment.

Douglas C Chung, Noor Shakfa, Jehan Vakharia

|Jun 15, 2022
Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.

Patrycja K Thompson, Edward L Y Chen, Renée F de Pooter

|May 04, 2021
Cutting Edge: TCR-β Selection Is Required at the CD4+CD8+ Stage of Human T Cell Development.

Edward L Y Chen, Patrick M Brauer, Elisa C Martinez

|Sep 28, 2018
Peroxisome Proliferator-Activated Receptor-δ Supports the Metabolic Requirements of Cell Growth in TCRβ-Selected Thymocytes and Peripheral CD4+ T Cells.

Fei Linda Zhao, Jeeyoon Jennifer Ahn, Edward L Y Chen

Pageof 1

Frequent Collaborators

4 joint publications

Juan Carlos Zúñiga-Pflücker

2 joint publications

Michele K Anderson

1 joint publications

Jeeyoon Jennifer Ahn

1 joint publications

Yang Li